CIRM is paving the way for a diverse and skilled workforce in regenerative medicine throughout the Golden State. Check out this video highlighting mentors, students, clinical fellows, and program alums as they share their journey and the invaluable support they've received. #CIRM #DiversityInScience #IgnitingInnovation
California Institute for Regenerative Medicine (CIRM)
Biotechnology Research
South San Francisco, California 8,197 followers
California's Stem Cell Agency
About us
The California Institute for Regenerative Medicine (CIRM) is California's stem cell agency. Our mission is to accelerate world class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse California and world.
- Website
-
https://www.cirm.ca.gov
External link for California Institute for Regenerative Medicine (CIRM)
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- South San Francisco, California
- Type
- Government Agency
- Founded
- 2004
- Specialties
- Stem Cell Research, Regenerative Medicine, Funding Agency, and Clinical Trials
Locations
-
Primary
601 Gateway Blvd
400
South San Francisco, California 94080, US
Employees at California Institute for Regenerative Medicine (CIRM)
-
Anne-Marie Duliege
Deputy Director| C-Suite Executive | Chief Medical Officer | Board Governance | Biopharma & Nonprofit Healthcare Organizations | Drug Development…
-
Ted Goldstein
-
Maria Gonzalez Bonneville
-
Lisa Kadyk
Associate Director, Therapeutics at California Institute for Regenerative Medicine
Updates
-
Ground-breaking progress in stem cell and gene therapies for vision loss are being made! Hear from clinicians and patients in CIRM-funded trials at our "Exploring Advances in Eye Disease and Regenerative Medicine" webinar on August 8, 12:30-1:30 PM. Register now to learn about current advancements, future directions, and what's next for vision loss therapies: https://lnkd.in/gF29xjFA
-
Exciting update from the world of stem cell research! A seventh individual has achieved HIV remission following a stem cell transplant nearly a decade ago. This 60-year-old German man, who also battled acute myeloid leukemia, has been off anti-retroviral drugs since 2018 and shows no signs of HIV or cancer. This breakthrough highlights stem cell research's transformative potential. To date, CIRM has funded more than $104 million for HIV research and projects.
-
Dr. Noriyuki Kasahara from the University of California, San Francisco, has received an $11.8 million award from CIRM to advance a groundbreaking clinical trial targeting newly diagnosed high-grade gliomas. This innovative gene therapy, DB107, aims to convert a harmless compound into a potent cancer-fighting drug directly within tumor cells, potentially transforming brain cancer treatment.
Gene therapy trial tests cancer-killing virus in brain tumors
http://blog.cirm.ca.gov
-
With the support of a $6 million CIRM grant, Dr. Arjun Deb and his team at UCLA are advancing a pioneering treatment for heart attack and heart failure. Their therapeutic antibody targets ENPP1 to reduce post-heart attack inflammation and fibrosis, aiming to prevent heart failure and improve patient outcomes.
CIRM awards $6 million to advance research for heart attack and heart failure treatments
http://blog.cirm.ca.gov
-
CIRM has awarded $53 million to support a range of projects, from heart failure prevention to advancing cell therapy for Parkinson’s disease and targeting various cancers. #CIRM #RegenerativeMedicine #TranslationalResearch #ClinicalResearch #ParkinsonsDisease #StemCellResearch #GeneTherapy
$53 million awarded to fund clinical and translational research
http://blog.cirm.ca.gov
-
A team of scientists at the Gladstone Institutes—with funding support from CIRM and various institutions— has created a new method to simultaneously make precise edits in multiple locations within a cell. This breakthrough uses retrons, distinct DNA sequences that code for a reverse transcriptase (RT), to modify DNA efficiently in bacteria, yeast, and human cells. The ability to edit multiple genome locations at the same time opens new possibilities for studying complex diseases and developing advanced therapies.
New One-Step Method to Make Multiple Edits to a Cell’s Genome
gladstone.org
-
The California Institute for Regenerative Medicine (CIRM) is pleased to announce the appointment of Jonathan Thomas, PhD, JD, as CIRM’s President and CEO. Dr. Thomas—who is also known as JT—previously served as the ICOC Board Chair, a position he held for 12 years up to 2023, and most recently, as CIRM’s Interim CEO. “It is a privilege to take over as the official CEO and President of this incredible organization. Over the past six months, our outstanding team has made significant strides developing a game plan for how to best use the remaining Prop 14 funds for the greatest benefits for patients throughout California. As we approach our 20th anniversary, I am eager to lead CIRM into this next phase by building on our achievements and accelerating the development of transformative therapies,” said Dr. Thomas. Read the full announcement: https://lnkd.in/dPSP7sn9
-
We are excited to announce CIRM's logo refresh! Over the past 20 years, our logo has evolved to reflect our growth and transformation. Our new design continues this tradition, embodying our commitment to innovation and excellence while staying true to our core values. This brand refresh reflects who we are today and symbolizes our dynamic future. #CIRM #LogoRefresh #BrandRefresh #NewLogo #BrandUpdate